| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.64B | 31.31B | 30.55B | 30.31B | 31.39B | 29.41B |
| Gross Profit | 6.55B | 7.06B | 7.07B | 7.46B | 6.55B | 7.29B |
| EBITDA | 3.95B | 4.40B | 3.99B | 4.37B | 3.41B | 4.11B |
| Net Income | 1.85B | 1.97B | 1.92B | 2.04B | 1.20B | 1.93B |
Balance Sheet | ||||||
| Total Assets | 63.24B | 68.01B | 63.02B | 61.01B | 54.60B | 54.68B |
| Cash, Cash Equivalents and Short-Term Investments | 11.17B | 11.69B | 10.95B | 9.55B | 9.26B | 10.69B |
| Total Debt | 657.00M | 665.00M | 773.00M | 755.00M | 709.00M | 675.00M |
| Total Liabilities | 11.35B | 11.16B | 11.28B | 10.73B | 8.49B | 9.78B |
| Stockholders Equity | 50.05B | 54.65B | 49.75B | 48.53B | 44.56B | 43.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -591.00M | 1.38B | 1.82B | -533.00M | 1.28B |
| Operating Cash Flow | 0.00 | 4.58B | 4.33B | 3.64B | 1.20B | 2.45B |
| Investing Cash Flow | 0.00 | -2.76B | -2.81B | -2.16B | -2.46B | -942.00M |
| Financing Cash Flow | 0.00 | -825.00M | -875.00M | -774.00M | -687.00M | -746.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥29.82B | 14.81 | ― | 3.63% | 43.31% | 13.90% | |
72 Outperform | ¥34.82B | 9.31 | ― | 2.37% | -1.11% | -3.98% | |
72 Outperform | ¥35.45B | 8.84 | ― | 1.90% | -0.76% | 25.33% | |
65 Neutral | ¥28.27B | 17.68 | ― | 2.47% | 2.49% | 2.71% | |
64 Neutral | ¥27.20B | 11.36 | ― | 4.27% | 2.37% | -16.75% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥43.39B | -4.57 | ― | 3.24% | 2.94% | -136.46% |